BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32372022)

  • 21. Expanding the clinicopathologic and molecular spectrum of BCOR-associated sarcomas in adults.
    Yoshida A; Arai Y; Hama N; Chikuta H; Bando Y; Nakano S; Kobayashi E; Shibahara J; Fukuhara H; Komiyama M; Watanabe SI; Tamura K; Kawai A; Shibata T
    Histopathology; 2020 Mar; 76(4):509-520. PubMed ID: 31647130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BCOR internal tandem duplication and YWHAE-NUTM2B/E fusion are mutually exclusive events in clear cell sarcoma of the kidney.
    Karlsson J; Valind A; Gisselsson D
    Genes Chromosomes Cancer; 2016 Feb; 55(2):120-3. PubMed ID: 26493387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic features of undifferentiated round cell sarcomas of bone & soft tissues: An attempt to unravel the
    Rekhi B; Kembhavi P; Mishra SN; Shetty O; Bajpai J; Puri A
    Indian J Med Res; 2019 Dec; 150(6):557-574. PubMed ID: 32048619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.
    Kommoss FKF; Chiang S; Köbel M; Koelsche C; Chang KT; Irving JA; Dickson B; Thiryayi S; Rouzbahman M; Rasty G; von Deimling A; Lee CH; Turashvili G
    Am J Surg Pathol; 2022 Aug; 46(8):1142-1152. PubMed ID: 35499168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCOR-CCNB3 Undifferentiated Sarcoma-Does Immunohistochemistry Help in the Identification?
    Ludwig K; Alaggio R; Zin A; Peron M; Guzzardo V; Benini S; Righi A; Gambarotti M
    Pediatr Dev Pathol; 2017; 20(4):321-329. PubMed ID: 28420319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion.
    Wong MK; Ng CCY; Kuick CH; Aw SJ; Rajasegaran V; Lim JQ; Sudhanshi J; Loh E; Yin M; Ma J; Zhang Z; Iyer P; Loh AHP; Lian DWQ; Wang S; Goh SGH; Lim TH; Lim AST; Ng T; Goytain A; Loh AHL; Tan PH; Teh BT; Chang KTE
    Histopathology; 2018 Jan; 72(2):320-329. PubMed ID: 28833375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations.
    Merjaneh N; Kim H; Escoto H; Metts J; Ray A; Bukowinski A; LeBlanc Z; Fair D; Watanbe M; Alva E; Todd K; Daley J; Hartt D; Cramer SL; Szabo S; Pressey JG
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):315-321. PubMed ID: 36706311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCOR-CCNB3-positive soft tissue sarcoma with round-cell and spindle-cell histology: a series of four cases highlighting the pitfall of mimicking poorly differentiated synovial sarcoma.
    Li WS; Liao IC; Wen MC; Lan HH; Yu SC; Huang HY
    Histopathology; 2016 Nov; 69(5):792-801. PubMed ID: 27228320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
    Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical relevance of BCOR internal tandem duplication and TP53 aberration in clear cell sarcoma of the kidney.
    Zhang M; Yao X; Guan X; Jia C; Zhang R; Wang H; Guo Y; Ni X; Yu Y; He L
    Hum Pathol; 2023 Apr; 134():45-55. PubMed ID: 36563883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family.
    Bouchoucha Y; Tauziède-Espariat A; Gauthier A; Guillemot D; Bochaton D; Vibert J; Carton M; Watson S; Grossetête S; Quignot C; Orbach D; Corradini N; Schleiermacher G; Bourdeaut F; Simbozel M; Dufour C; Minard-Colin V; Brahmi M; Tirode F; Pissaloux D; Karanian M; Machet MC; Masliah-Planchon J; Delattre O; Cardoen L; Pierron G; Doz F
    J Pathol Clin Res; 2022 May; 8(3):217-232. PubMed ID: 35174661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific and Sensitive Diagnosis of
    Barets D; Appay R; Heinisch M; Battistella M; Bouvier C; Chotard G; Le Loarer F; Macagno N; Perbet R; Pissaloux D; Rousseau A; Tauziède-Espariat A; Varlet P; Vasiljevic A; Colin C; Fina F; Figarella-Branger D
    Front Oncol; 2021; 11():645512. PubMed ID: 33718245
    [No Abstract]   [Full Text] [Related]  

  • 33. Spectrum of Histopathological, Immunohistochemical, Molecular and Radiological Features in 12 Cases of
    Rekhi B; Kosemehmetoglu K; Ergen FB; Vengurlekar V; Rumde R; Shetty O; Guler G
    Int J Surg Pathol; 2023 Oct; 31(7):1244-1264. PubMed ID: 36591870
    [No Abstract]   [Full Text] [Related]  

  • 34. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
    Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
    Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney.
    Han H; Bertrand KC; Patel KR; Fisher KE; Roy A; Muscal JA; Venkatramani R
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28151. PubMed ID: 31876361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCOR involvement in cancer.
    Astolfi A; Fiore M; Melchionda F; Indio V; Bertuccio SN; Pession A
    Epigenomics; 2019 May; 11(7):835-855. PubMed ID: 31150281
    [No Abstract]   [Full Text] [Related]  

  • 37. Central nervous system high grade neuroepithelial tumor with BCOR immunopositivity: Is there a molecular heterogeneity?
    Rao S; Mitra S; Sugur H; Vazhayil V; Rao BRM; Annayappa SK; Nandeesh BN; Yasha TC; Santosh V
    Brain Tumor Pathol; 2021 Jan; 38(1):41-49. PubMed ID: 32980923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.
    Kenny C; Bausenwein S; Lazaro A; Furtwängler R; Gooskens SL; van den Heuvel Eibrink M; Vokuhl C; Leuschner I; Graf N; Gessler M; O'Sullivan MJ
    J Pathol; 2016 Apr; 238(5):617-20. PubMed ID: 27000436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. JAZF1, YWHAE and BCOR gene translocation in primary extrauterine low-grade and high-grade endometrial stromal sarcomas.
    Sun L; Zhao W; Zhao Z; Zhu Y
    Histopathology; 2022 Apr; 80(5):809-819. PubMed ID: 34843125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.